, , , ,

The Increasing Role of Dual Immunotherapy in mNSCLC Patients

Faculty: Biagio Ricciuti, MD, PhD
Disclosures

Download Slides

Panelists

Biagio Ricciuti, MD, PhD

Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
Department of Medicine
Harvard Medical School

Discover more from OmniOncology.net

Subscribe now to keep reading and get access to the full archive.

Continue reading